Modeling and analysis of COVID-19 based on a time delay dynamic model
Related Experiment Video
Updated: Nov 19, 2025

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
Cong Yang1, Yali Yang1, Zhiwei Li1
1Department of Basic Sciences, Air Force Engineering University, Xioan 710051, China.
Abstract:
The new type of coronavirus pneumonia is caused by the new type of coronavirus which appeared at the end of 2019. Because of its strong contagiousness, rapid spread and great harm, it has already given countries around the world serious effects. So far there is no clear specific drug. Scientifically grasping the development law of epidemics is extremely important for preventing and controlling epidemics. Since the latent of this epidemic are also highly contagious, traditional infectious disease models cannot accurately describe the regularity of this epidemic transmission. Based on the traditional infectious disease model, an infectious disease model with a time delay is proposed. The time difference is used to characterize the cycle of viral infection and treatment time. Using the epidemic data released in real time, firstly, through the numerical simulation parameter inversion, the minimum error is obtained; then we simulate the development trend of the epidemic according to the dynamics system; finally, we compare and analyze the effectiveness of isolation measures. This article has simulated COVID-19 and analyzed the development of the epidemic in Beijing and Wuhan. By comparing the severity of the epidemic in the two regions, early detection and isolation are still the top priority of epidemic prevention and control.
Related Concept Videos
Steps in Outbreak Investigation
Exponential Equations for Modeling Growth
Causality in Epidemiology
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Linear time-invariant Systems
The input-output behavior of an LTI system can be fully defined by its response to an impulsive excitation at its input. Once this impulse response is known, the system's reaction to any other input can be...
Model Approaches for Pharmacokinetic Data: Physiological Models

